Neutrophil-to-albumin Ratio as a Prognostic Factor in Patients with Acute Ischemic Stroke

Jiajia      Bao; Yang      Zhang; Mengmeng      Ma; Jian      Wang; Xin      Jiang; Jian      Guo; Li      He

doi:10.2174/0115672026328594240614080241

Note! Please note that this article is currently in the "Article in Press" stage and is not the final "Version of record". While it has been accepted, copy-edited, and formatted, however, it is still undergoing proofreading and corrections by the authors. Therefore, the text may still change before the final publication. Although "Articles in Press" may not have all bibliographic details available, the DOI and the year of online publication can still be used to cite them. The article title, DOI, publication year, and author(s) should all be included in the citation format. Once the final "Version of record" becomes available the "Article in Press" will be replaced by that.

Abstract

Background: Neutrophil-To-Albumin Ratio (NAR) is a novel inflammatory biomarker. However, the potential prognostic value of NAR in acute ischemic stroke (AIS) remains unclear. This study aimed to evaluate whether NAR levels correlated with the 3-month modified Rankin scale (mRS) in patients with AIS.

Methods: AIS patients were included in this retrospective study. NAR was calculated as the ratio of absolute neutrophil count to serum albumin level. Logistic regression analyses were used to investigate the effect of NAR on 3-month mRS of AIS. The predictive values of NAR, albumin level, and neutrophil count were compared utilizing receiver operating characteristic (ROC) curves. Moreover, subgroup analyses and interaction tests were conducted to evaluate the consistency of NAR’s effect on AIS prognosis.

Results: Of the 780 patients included, 403 (51.67%) had a poor clinical outcome (mRS 3-6) at 3 months. NAR was independently correlated to 3-month poor functional outcome after adjusting for confounders (Odds ratios (OR), 9.34; 95% confidence intervals (CI), 1.09 to 80.13; p =0.0417). Subgroup analysis showed a relative effect consistent with the overall population results, and no statistical interactions were found in the subgroups (all p for interaction > 0.05). The ROC curve showed that the prognosis-related cutoff value for NAR was 0.123, with corresponding specificity and sensitivity of 53.55% and 63.94%, respectively. When comparing the predictive power, NAR (0.590; 95%CI 0.549–0.630) exhibited the highest area under the curve (AUC) of ROC compared to neutrophils (0.584; 95%CI 0.543–0.624) and albumin (0.540; 95%CI 0.500–0.581).

Conclusion: There is a positive relationship between NAR levels and 3-month poor functional outcomes in AIS patients, supporting the potential of NAR as a readily available and economic serum biomarker for the early identification of AIS prognosis. Further studies are required to validate the prognostic value and clinical utility of the NAR.

[1]
Cieza A, Causey K, Kamenov K, Hanson SW, Chatterji S, Vos T. Global estimates of the need for rehabilitation based on the Global Burden of Disease study 2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet  2020; 396(10267): 2006-17.
 [http://dx.doi.org/10.1016/S0140-6736(20)32340-0] [PMID: 33275908]

[2]
Vos T, Lim SS, Abbafati C, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet  2020; 396(10258): 1204-22.
 [http://dx.doi.org/10.1016/S0140-6736(20)30925-9] [PMID: 33069326]

[3]
Phipps MS, Cronin CA. Management of acute ischemic stroke. BMJ  2020; 368: l6983.
 [http://dx.doi.org/10.1136/bmj.l6983] [PMID: 32054610]

[4]
Slot KB, Berge E, Dorman P, Lewis S, Dennis M, Sandercock P. Impact of functional status at six months on long term survival in patients with ischaemic stroke: Prospective cohort studies. BMJ  2008; 336(7640): 376-9.
 [http://dx.doi.org/10.1136/bmj.39456.688333.BE] [PMID: 18230644]

[5]
Choi DH, Kobayashi Y, Nishi T, et al. Combination of mean platelet volume and neutrophil to lymphocyte ratio predicts long-term major adverse cardiovascular events after percutaneous coronary intervention. Angiology  2019; 70(4): 345-51.
 [http://dx.doi.org/10.1177/0003319718768658] [PMID: 29631419]

[6]
Yang YL, Wu CH, Hsu PF, et al. Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease. Eur J Clin Invest  2020; 50(5): e13230.
 [http://dx.doi.org/10.1111/eci.13230] [PMID: 32291748]

[7]
Brooks SD, Spears C, Cummings C, et al. Admission neutrophil–lymphocyte ratio predicts 90 day outcome after endovascular stroke therapy. J Neurointerv Surg  2014; 6(8): 578-83.
 [http://dx.doi.org/10.1136/neurintsurg-2013-010780] [PMID: 24122003]

[8]
Planas AM. Role of immune cells migrating to the ischemic brain. Stroke  2018; 49(9): 2261-7.
 [http://dx.doi.org/10.1161/STROKEAHA.118.021474] [PMID: 30355002]

[9]
Petrovic-Djergovic D, Goonewardena SN, Pinsky DJ. Inflammatory disequilibrium in stroke. Circ Res  2016; 119(1): 142-58.
 [http://dx.doi.org/10.1161/CIRCRESAHA.116.308022] [PMID: 27340273]

[10]
Lux D, Alakbarzade V, Bridge L, et al. The association of neutrophil-lymphocyte ratio and lymphocyte-monocyte ratio with 3 month clinical outcome after mechanical thrombectomy following stroke. J Neuroinflammation  2020; 17(1): 60.
 [http://dx.doi.org/10.1186/s12974-020-01739-y] [PMID: 32070366]

[11]
Chung D, Lee KO, Choi JW, et al. Blood neutrophil/lymphocyte ratio is associated with cerebral large-artery atherosclerosis but not with cerebral small-vessel disease. Front Neurol  2020; 11: 1022.
 [http://dx.doi.org/10.3389/fneur.2020.01022] [PMID: 33013672]

[12]
Weng Y, Zeng T, Huang H, et al. Systemic immune-inflammation index predicts 3-month functional outcome in acute ischemic stroke patients treated with intravenous thrombolysis. Clin Interv Aging  2021; 16: 877-86.
 [http://dx.doi.org/10.2147/CIA.S311047] [PMID: 34040364]

[13]
Kamtchum-Tatuene J, Jickling GC. Blood biomarkers for stroke diagnosis and management. Neuromolecular Med  2019; 21(4): 344-68.
 [http://dx.doi.org/10.1007/s12017-019-08530-0] [PMID: 30830566]

[14]
Pinčáková K, Krastev G, Haring J. Low lymphocyte-to-monocyte ratio as a possible predictor of an unfavourable clinical outcome in patients with acute ischemic stroke after mechanical thrombectomy. Stroke Res Treat.   2022; 2022: p. 9243080.

[15]
Zhang X, Zhang S, Wang C, Li A. Neutrophil-to-albumin ratio as a novel marker predicting unfavorable outcome in aneurysmal subarachnoid hemorrhage. J Clin Neurosci  2022; 99: 282-8.
 [http://dx.doi.org/10.1016/j.jocn.2022.03.027] [PMID: 35325726]

[16]
Shin KW, Choi S, Oh H, Hwang SY, Park HP. A high immediate postoperative neutrophil-to-albumin ratio is associated with unfavorable clinical outcomes at hospital discharge in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol  2024; 36(2): 142-9.
 [http://dx.doi.org/10.1097/ANA.0000000000000906] [PMID: 36791399]

[17]
Li X, Zhang C, Wang J, Ye C, Zhu J, Zhuge Q. Development and performance assessment of novel machine learning models for predicting postoperative pneumonia in aneurysmal subarachnoid hemorrhage patients: External validation in MIMIC-IV. Front Neurol  2024; 15: 1341252.
 [http://dx.doi.org/10.3389/fneur.2024.1341252] [PMID: 38685951]

[18]
Zhao J, Feng J, Ma Q, Li C, Qiu F. Prognostic value of inflammation biomarkers for 30-day mortality in critically ill patients with stroke. Front Neurol  2023; 14: 1110347.
 [http://dx.doi.org/10.3389/fneur.2023.1110347] [PMID: 36814998]

[19]
Varim C, Celik FD, Sunu C, et al. The role of neutrophil albumin ratio in predicting the stage of non-small cell lung cancer. Eur Rev Med Pharmacol Sci  2022; 26(8): 2900-5.
 [PMID: 35503633]

[20]
Feng C, Yu H, Lei H, Cao H, Chen M, Liu S. A prognostic model using the neutrophil-albumin ratio and PG-SGA to predict overall survival in advanced palliative lung cancer. BMC Palliat Care  2022; 21(1): 81.
 [http://dx.doi.org/10.1186/s12904-022-00972-x] [PMID: 35585628]

[21]
Tawfik B, Mokdad AA, Patel PM, Li HC, Huerta S. The neutrophil to albumin ratio as a predictor of pathological complete response in rectal cancer patients following neoadjuvant chemoradiation. Anticancer Drugs  2016; 27(9): 879-83.
 [http://dx.doi.org/10.1097/CAD.0000000000000411] [PMID: 27434664]

[22]
Xie H, Wei L, Liu M, et al. Neutrophil-albumin ratio as a biomarker for postoperative complications and long-term prognosis in patients with colorectal cancer undergoing surgical treatment. Front Nutr  2022; 9: 976216.
 [http://dx.doi.org/10.3389/fnut.2022.976216] [PMID: 36458178]

[23]
Bao B, Xu S, Sun P, Zheng L. Neutrophil to albumin ratio: A biomarker in non-alcoholic fatty liver disease and with liver fibrosis. Front Nutr  2024; 11: 1368459.
 [http://dx.doi.org/10.3389/fnut.2024.1368459] [PMID: 38650638]

[24]
Cuschieri S. The STROBE guidelines. Saudi J Anaesth  2019; 13(5) (Suppl. 1): 31.
 [http://dx.doi.org/10.4103/sja.SJA_543_18] [PMID: 30930717]

[25]
Larrue V, von Kummer R, del Zoppo G, Bluhmki E. Hemorrhagic transformation in acute ischemic stroke. Potential contributing factors in the European Cooperative Acute Stroke Study. Stroke  1997; 28(5): 957-60.
 [http://dx.doi.org/10.1161/01.STR.28.5.957] [PMID: 9158632]

[26]
Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke  1993; 24(1): 35-41.
 [http://dx.doi.org/10.1161/01.STR.24.1.35] [PMID: 7678184]

[27]
Cui C, Li Y, Bao J, Dong S, Gao L, He L. Low dose statins improve prognosis of ischemic stroke patients with intravenous thrombolysis. BMC Neurol  2021; 21(1): 220.
 [http://dx.doi.org/10.1186/s12883-021-02259-9] [PMID: 34107911]

[28]
Zhao L, Du W, Zhao X, et al. Favorable functional recovery in overweight ischemic stroke survivors: Findings from the China National Stroke Registry. J Stroke Cerebrovasc Dis  2014; 23(3): e201-6.
 [http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2013.10.002] [PMID: 24231138]

[29]
Chen RL, Balami JS, Esiri MM, Chen LK, Buchan AM. Ischemic stroke in the elderly: An overview of evidence. Nat Rev Neurol  2010; 6(5): 256-65.
 [http://dx.doi.org/10.1038/nrneurol.2010.36] [PMID: 20368741]

[30]
Ceulemans AG, Zgavc T, Kooijman R, Hachimi-Idrissi S, Sarre S, Michotte Y. The dual role of the neuroinflammatory response after ischemic stroke: Modulatory effects of hypothermia. J Neuroinflammation  2010; 7(1): 74.
 [http://dx.doi.org/10.1186/1742-2094-7-74] [PMID: 21040547]

[31]
Wanrooy BJ, Wen SW, Wong CHY. Dynamic roles of neutrophils in post-stroke neuroinflammation. Immunol Cell Biol  2021; 99(9): 924-35.
 [http://dx.doi.org/10.1111/imcb.12463] [PMID: 33894069]

[32]
Chen R, Zhang X, Gu L, et al. New insight into neutrophils: A potential therapeutic target for cerebral ischemia. Front Immunol  2021; 12: 692061.
 [http://dx.doi.org/10.3389/fimmu.2021.692061] [PMID: 34335600]

[33]
Mu Q, Yao K, Syeda MZ, et al. Neutrophil targeting platform reduces neutrophil extracellular traps for improved traumatic brain injury and stroke theranostics. Adv Sci (Weinh)  2024; 2024: 2308719.
 [http://dx.doi.org/10.1002/advs.202308719] [PMID: 38520727]

[34]
Gao X, Zhao X, Li J, et al. Neutrophil extracellular traps mediated by platelet microvesicles promote thrombosis and brain injury in acute ischemic stroke. Cell Commun Signal  2024; 22(1): 50.
 [http://dx.doi.org/10.1186/s12964-023-01379-8] [PMID: 38233928]

[35]
Urban CF, Ermert D, Schmid M, et al. Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans. PLoS Pathog  2009; 5(10): e1000639.
 [http://dx.doi.org/10.1371/journal.ppat.1000639] [PMID: 19876394]

[36]
Li C, Xing Y, Zhang Y, Hua Y, Hu J, Bai Y. Neutrophil extracellular traps exacerbate ischemic brain damage. Mol Neurobiol  2022; 59(1): 643-56.
 [http://dx.doi.org/10.1007/s12035-021-02635-z] [PMID: 34748205]

[37]
Belayev L, Pinard E, Nallet H, et al. Albumin therapy of transient focal cerebral ischemia: In vivo analysis of dynamic microvascular responses. Stroke  2002; 33(4): 1077-84.
 [http://dx.doi.org/10.1161/hs0402.105555] [PMID: 11935064]

[38]
Dziedzic T, Pera J, Wnuk M, Szczudlik A, Slowik A. Serum albumin as a determinant of cortisol release in patients with acute ischemic stroke. Atherosclerosis  2012; 221(1): 212-4.
 [http://dx.doi.org/10.1016/j.atherosclerosis.2011.12.017] [PMID: 22245038]

[39]
Jacobson L, Zurakowski D, Majzoub JA. Protein malnutrition increases plasma adrenocorticotropin and anterior pituitary proopiomelanocortin messenger ribonucleic acid in the rat. Endocrinology  1997; 138(3): 1048-57.
 [http://dx.doi.org/10.1210/endo.138.3.5011] [PMID: 9048608]

[40]
Barugh AJ, Gray P, Shenkin SD, MacLullich AMJ, Mead GE. Cortisol levels and the severity and outcomes of acute stroke: A systematic review. J Neurol  2014; 261(3): 533-45.
 [http://dx.doi.org/10.1007/s00415-013-7231-5] [PMID: 24477489]

[41]
Martineau J, Bauer J, Isenring E, Cohen S. Malnutrition determined by the patient-generated subjective global assessment is associated with poor outcomes in acute stroke patients. Clin Nutr  2005; 24(6): 1073-7.
 [http://dx.doi.org/10.1016/j.clnu.2005.08.010] [PMID: 16213064]

Rights & Permissions Print Cite

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

DOI https://dx.doi.org/10.2174/0115672026328594240614080241	Print ISSN 1567-2026
Publisher Name Bentham Science Publisher	Online ISSN 1875-5739

Current Neurovascular Research

Neutrophil-to-albumin Ratio as a Prognostic Factor in Patients with Acute Ischemic Stroke

Abstract Play Pause

Related Journals

Related Books

Abstract